Health & Medicine

Latest press releases filed to this category.

HepaRegeniX GmbH ·

HepaRegeniX Completes Darizmetinib Trial for Liver Cancer Patients

Clinical-stage biotech company HepaRegeniX GmbH has announced the successful completion of the Phase 1b of its clinical trial for darizmetinib, a novel therapy aimed at treating acute and chronic liver diseases. The first patient to undergo major liver resection for …

American Lung Association ·

American Lung Association Hosts Advocacy Day in DC

CHICAGO -- The American Lung Association is hosting its fourth Respiratory Advocacy Day in Washington, D.C. on September 24, bringing together people living with chronic lung diseases from across the country to meet with members of …

AstronauTx Ltd ·

AstronauTx Receives Funding to Explore Sleep-Based Parkinson's Treatment

LONDON -- AstronauTx Ltd, a biotechnology company focused on developing novel therapeutics for neurological diseases by improving sleep architecture, has received significant funding to explore sleep-based approaches for Parkinson's disease. The company has been awarded a …

Beactica Therapeutics AB ·

Beactica Therapeutics Initiates IND-Enabling Studies for Novel Glioblastoma Treatment

UPPSALA, Sweden -- Beactica Therapeutics AB, a Swedish precision medicine company, has taken a significant step forward in its quest to develop a novel treatment for glioblastoma, the most common and aggressive primary brain tumour. The …

Respiree ·

Respiree Expands Series A Syndicate with International Investors

HOUSTON and SINGAPORE -- HOUSTON and SINGAPORE, Sept. 21, 2026 /CourierPR/ -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, has expanded its Series A syndicate with the addition of ARKRAY & PARTNERS Pte.

Balanced Dental Studio ·

Balanced Dental Studio Offers Affordable Membership Plans

The Dental Health Advocacy Group, a practice in Lakewood, Colorado, is launching a new membership plan to coincide with National Dental Hygiene Month, which takes place in October. The practice, known as Balanced Dental Studio, is offering a membership plan …

Helus Pharma ·

Helus Pharma CEO to Participate in Neuropsychiatry Summit Webinar

NEW YORK and TORONTO -- NEW YORK and TORONTO, Sept. 21, 2026 /CourierPR/ -- Helus Pharma, a clinical-stage pharmaceutical company committed to developing novel serotonergic agonists, announced that Michael Halstead, Helus Pharma’s Chief Executive Officer, will participate in a fireside chat at the TD Cowen …

NYU Langone Health ·

Dr. Mehta joins Perlmutter Cancer Center as new upper GI medical oncology director

NEW YORK -- Rutika Mehta, MD, MPH, has joined NYU Langone Health’s Perlmutter Cancer Center as the new director of upper GI medical oncology. The appointment marks a significant step in the center’s ongoing growth and …

Wissen Research LLC ·

Immunoassay Market to Reach USD 47.5B by 2031 with 6% CAGR Growth

SHERIDAN, Wyo. -- The global immunoassay market is projected to grow from USD 35.5 billion in 2026 to USD 47.5 billion by 2031, registering a CAGR of 6% during the forecast period (2026-2031), according to a …

Dr. Wade Newman Scholarship for Future Doctors ·

Dr. Wade Newman Scholarship for Future Doctors Opens Applications

BELLEFONTE, Pa. -- The Dr. Wade Newman Scholarship for Future Doctors, a new scholarship opportunity for aspiring medical professionals, is now open for applications. Established to support undergraduate students pursuing careers in medicine, the scholarship invites …

Legal Experts AI ·

Top Dental Expert Witnesses Announced by Legal Experts AI

Legal Experts AI, a platform that connects attorneys and clients with thoroughly vetted expert witnesses, has announced its selection of the top dental expert witnesses in practice in the United States. Each professional on this list has built a reputation …

Alzinova AB ·

Alzinova Advances Therapeutic Vaccine and Blood Diagnostic for Alzheimer’s

GOTHENBURG, Sweden -- Alzinova AB, a Swedish clinical-stage biopharmaceutical company, is advancing its dual approach to Alzheimer’s disease, as the world marks World Alzheimer’s Day. The company is set to initiate a global Phase II clinical …

Siemens Healthineers ·

Siemens Healthineers, Novo Collaborate on Liver Disease Care

Tarrytown, New York, USA -- Siemens Healthineers and Novo have announced a collaboration aimed at advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The …

Defense Strategies Institute ·

DSI Hosts Annual Military Medicine Symposium

The 2027 Operational Medicine Symposium & Technology Showcase (OPMED), one of the largest and most influential military medical events in North America, is set to convene in San Antonio, TX, from March 2-4, 2027. The symposium, now in its ninth …

Regenerative Medical Technology Group ·

Regenerative Medicine Group Hosts Global Summit in Cancun

MIAMI -- Regenerative Medical Technology Group Inc., a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the 2026 ISSCA Global Summit, ISSCA 125, taking place September 25-27 at the …

Medicus Pharma Ltd ·

Medicus Pharma Focusing SkinJect® on Gorlin Syndrome Patients

PHILADELPHIA -- Medicus Pharma Ltd., a precision-guided biotech/life sciences company, has announced a strategic shift in its clinical development focus for its SkinJect® product. The company will now concentrate its efforts exclusively on patients with Gorlin …

Helus Pharma ·

Helus Pharma Presents HLP003 Analyses at Psych Congress

NEW YORK and TORONTO -- NEW YORK and TORONTO, Sept. 21, 2026 /CourierPR/ -- Helus Pharma, a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists ("NSAs"), has presented four posters at Psych Congress 2026, September 15-19, 2026, in New Orleans, …

Tiziana Life Sciences Ltd ·

Tiziana Completes Key Phase 2a Trial for Multiple Sclerosis Treatment

BOSTON -- Tiziana Life Sciences, a biotechnology company developing breakthrough immunomodulation therapies, today announced that the last patient has completed their last visit in the Phase 2a clinical trial of intranasal foralumab, a fully human anti-CD3 …

OS Therapies ·

OS Therapies Secures Alignment for Phase 3 Trial of OST-HER2

OS Therapies, Inc. (NYSE American: OSTX), the world leader in gene-edited, Listeria-based cancer immunotherapies, has made significant progress in its regulatory efforts for the treatment of metastatic osteosarcoma. The company has secured alignment with the U.S. Food and Drug Administration …

QScreen AI Inc ·

QScreen AI Settles $681K Debt with Directors

QScreen AI Inc., an innovator in physiological AI screening and developer of an intelligence platform for clinical and occupational health applications, has announced a significant debt settlement. The company has agreed to settle an aggregate of $681,000 of indebtedness owing …

Grünenthal ·

Grünenthal Acquires Cancer Treatment for EBITDA Boost

AACHEN, Germany -- Grünenthal, a global leader in pain management and research, has announced its acquisition of Stivarga®, an oral treatment for specific advanced cancers. The acquisition, which is subject to customary closing conditions including regulatory …

Thiogenesis Therapeutics, Corp ·

Thiogenesis Initiates Clinical Studies for Nephropathic Cystinosis and Leigh Syndrome

Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company based in San Diego, California, has announced the results of its Annual and Special Meeting of Shareholders and provided a corporate update on its pipeline of sulfur-based therapeutics for serious pediatric diseases. The …

Beacon Therapeutics ·

Laru-zova Shows Promise in X-Linked Retinitis Pigmentosa Trial

Beacon Therapeutics today announced positive topline results from its pivotal VISTA trial evaluating laruparetigene zovaparvovec (laru-zova) for the treatment of X-linked retinitis pigmentosa (XLRP). The trial met its FDA-endorsed primary endpoint, demonstrating statistically significant low luminance visual acuity (LLVA) responder …

Intermountain Health ·

Preparing for Pregnancy: Key Steps and Tips from Experts

Social media influencers are increasingly discussing "trimester zero," the period before pregnancy when women focus on improving their health, diet, and physical fitness to prepare for the future. However, according to OB-GYNs and midwives at Intermountain Health, this content can …

Babyscripts ·

Babyscripts Named to TIME's World's Top HealthTech Companies 2026

Babyscripts, a leading virtual maternity care platform, has been included in TIME's World's Top HealthTech Companies 2026 list. The recognition highlights the company's impact in advancing more proactive, connected, and scalable maternity care through technology.

Par Health ·

Par Health Recalls Two Lots of Dexmedetomidine HCl Due to Particulate Matter

ROCHESTER, Mich. -- Par Health, a pharmaceutical company, has issued a voluntary nationwide recall of two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) due to the presence of particulate …

PHP Biotech ·

PHP Biotech Identifies uPAR as Entry Receptor for PHP53-nb

Southlake, Texas -- PHP Biotech, a US-based biotechnology company, has announced a significant breakthrough in its research on PHP53-nb, an investigational lead candidate designed to restore the p53 pathway in aggressive solid tumors. The company has …

Intermountain Health ·

Intermountain Health Offers Variety of Birth Options for Expectant Mothers

CITY, UT (PRUnderground) September 18th, 2026, Pregnant mothers at Intermountain Health have a variety of options when it comes to prenatal visits, labor and delivery, and postpartum care. Intermountain Health offers a team-based approach to care, allowing patients to choose …

Global Virus Network ·

Global Virus Network Reports Detections of H5N1 in Australian Mammals

TAMPA, Fla. -- The Global Virus Network (GVN) has issued a statement regarding the detection of highly pathogenic avian influenza A (H5N1) in several mammal species in Australia. The virus, which has been spreading globally, was …

Rosalind Franklin University of Medicine and Science ·

Rosalind Franklin University Opens Innovative Virtual Health System

Rosalind Franklin University of Medicine and Science (RFU) has unveiled its groundbreaking Virtual Health System (VHS), a state-of-the-art clinical training center designed to transform health education and prepare the next generation of healthcare professionals. Spanning more than 23,000 square feet, …

Heart Failure Society of America ·

Heart Failure Society of America Hosts Annual Scientific Meeting with Late-Breaking Clinical Research

The Heart Failure Society of America (HFSA) is set to host its 2026 Annual Scientific Meeting (ASM) from October 9-12 in Phoenix, Arizona. This year’s event will feature late-breaking clinical research that could significantly reshape heart failure treatment, covering areas …

Jiahui Health ·

China's Medical Tourism Surges as Hospitals Serve More International Patients

GENEVA -- China's healthcare sector is experiencing a significant surge in international medical tourism, according to a presentation at the World Trade Organization (WTO) Public Forum 2026. Dr. John K. Hsiang, Chairman of Jiahui Health's Executive …

Black Book Research ·

Black Book Releases 2027 Healthcare Policy Outlook

Black Book Research has released its 2027 U.S. Healthcare Policy Outlook, a comprehensive 66-page resource designed to help healthcare providers and payers navigate upcoming policy changes. The report, which includes 18 sections, 84 primary-source references, and a 20-question executive survey …

Ultragenyx Pharmaceutical, Inc ·

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

Silver Spring, Md. -- The U.S. Food and Drug Administration (FDA) has approved Fayuvi (rebisufligene etisparvovec-hopf), the first gene therapy for pediatric patients with Sanfilippo syndrome type A (MPS IIIA). This approval marks a significant milestone …

uMETHOD Health, Inc ·

uMETHOD Health Publishes Study Showing Favorable Cognitive Outcomes with AI-generated Care Plans

RALEIGH, N.C. -- uMETHOD Health, a healthtech company based in RTP, North Carolina, has published a peer-reviewed study documenting favorable cognitive outcomes for its AI-generated RestoreU care plans.

Intermountain Health Saint Joseph Hospital ·

Intermountain Health Saint Joseph Hospital Earns Magnet Recognition with Distinction

Intermountain Health Saint Joseph Hospital in Denver, Colorado, has earned Magnet Recognition with Distinction for Excellence in Nursing Care, the highest honor internationally for nursing excellence and recognition of outstanding safety and innovative care for patients. This is the third …

RXNT Named to TIME’s World’s Top HealthTech Companies List for Two Years Running

ANNAPOLIS, Md. -- RXNT, a Maryland-based healthcare technology company, has been named to TIME’s World’s Top HealthTech Companies of 2026 list for the second consecutive year. The recognition highlights RXNT’s commitment to developing innovative healthcare technology …

Telomir Pharmaceuticals, Inc ·

Telomir Pharmaceuticals Shows Telomir-Zn Improves Vision in Age-Related Macular Degeneration Model

MIAMI -- Telomir Pharmaceuticals, Inc., a clinical-stage biotechnology company, has announced significant findings from a peer-reviewed publication that demonstrates its small-molecule therapeutic Telomir-Zn can restore visual function and retinal structure in a model of age-related macular …

Subtle Medical, Inc ·

Subtle Medical Named to TIME's World's Top HealthTech Companies Again

Subtle Medical, a global leader in artificial intelligence (AI) solutions for medical imaging, has once again been recognized by TIME and Statista as one of the World's Top HealthTech Companies for the second consecutive year. This accolade comes on the …

National Comprehensive Cancer Network ·

NCCN Releases Guidelines to Tailor Cancer Care for Older Adults

The National Comprehensive Cancer Network (NCCN) has released a new patient resource aimed at helping older adults with cancer navigate their treatment journey. This guideline, designed for both patients and caregivers, emphasizes the importance of personalized assessments to tailor cancer …

Talk to the desk

Questions before you file?

Volume pricing, corrections, partnerships — whatever doesn't fit a form field. Tell us what you need and we'll size it properly.

Contact us